These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23285309)

  • 1. Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India.
    Stauch A; Duerr HP; Dujardin JC; Vanaerschot M; Sundar S; Eichner M
    PLoS Negl Trop Dis; 2012; 6(12):e1973. PubMed ID: 23285309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?
    Perry MR; Wyllie S; Prajapati VK; Feldmann J; Sundar S; Boelaert M; Fairlamb AH
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1227. PubMed ID: 21980542
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent.
    Dumetz F; Cuypers B; Imamura H; Zander D; D'Haenens E; Maes I; Domagalska MA; Clos J; Dujardin JC; De Muylder G
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.
    Singh N; Chatterjee M; Sundar S
    Parasit Vectors; 2014 Dec; 7():596. PubMed ID: 25515494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India.
    Subba Raju BV; Gurumurthy S; Kuhls K; Bhandari V; Schnonian G; Salotra P
    Parasitol Res; 2012 Oct; 111(4):1559-68. PubMed ID: 22752721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden.
    Vanaerschot M; De Doncker S; Rijal S; Maes L; Dujardin JC; Decuypere S
    PLoS One; 2011; 6(8):e23120. PubMed ID: 21829701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
    Pal S; Mandal A; Duttagupta S
    Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India.
    Thakur CP; Narayan S; Ranjan A
    Indian J Med Res; 2004 Sep; 120(3):166-72. PubMed ID: 15489554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
    Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
    J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis.
    Perry MR; Wyllie S; Raab A; Feldmann J; Fairlamb AH
    Proc Natl Acad Sci U S A; 2013 Dec; 110(49):19932-7. PubMed ID: 24167266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of visceral leishmaniasis (kala-azar) in India: no obvious signs of long-term success.
    Muniaraj M; Paramasivan R; Mariappan T; Arunachalam N; Sinha PK
    Trans R Soc Trop Med Hyg; 2012 Dec; 106(12):770-2. PubMed ID: 23102868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani.
    Potvin JE; Leprohon P; Queffeulou M; Sundar S; Ouellette M
    Clin Infect Dis; 2021 May; 72(10):e526-e532. PubMed ID: 32827255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort study.
    Perry MR; Prajapati VK; Menten J; Raab A; Feldmann J; Chakraborti D; Sundar S; Fairlamb AH; Boelaert M; Picado A
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003518. PubMed ID: 25730310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004.
    Olliaro PL; Guerin PJ; Gerstl S; Haaskjold AA; Rottingen JA; Sundar S
    Lancet Infect Dis; 2005 Dec; 5(12):763-74. PubMed ID: 16310148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection.
    Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Das AK; Roy S
    PLoS Negl Trop Dis; 2012; 6(12):e1987. PubMed ID: 23301108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages.
    de Moura TR; Santos ML; Braz JM; Santos LF; Aragão MT; de Oliveira FA; Santos PL; da Silva ÂM; de Jesus AR; de Almeida RP
    Parasitol Res; 2016 Feb; 115(2):713-21. PubMed ID: 26481489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of mitogen-activated protein kinase 1 of Leishmania donovani field isolates is associated with antimony resistance.
    Ashutosh ; Garg M; Sundar S; Duncan R; Nakhasi HL; Goyal N
    Antimicrob Agents Chemother; 2012 Jan; 56(1):518-25. PubMed ID: 22064540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of natural antimony resistance in Leishmania donovani isolates.
    Mittal MK; Rai S; Ashutosh ; Ravinder ; Gupta S; Sundar S; Goyal N
    Am J Trop Med Hyg; 2007 Apr; 76(4):681-8. PubMed ID: 17426170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent.
    Imamura H; Downing T; Van den Broeck F; Sanders MJ; Rijal S; Sundar S; Mannaert A; Vanaerschot M; Berg M; De Muylder G; Dumetz F; Cuypers B; Maes I; Domagalska M; Decuypere S; Rai K; Uranw S; Bhattarai NR; Khanal B; Prajapati VK; Sharma S; Stark O; Schönian G; De Koning HP; Settimo L; Vanhollebeke B; Roy S; Ostyn B; Boelaert M; Maes L; Berriman M; Dujardin JC; Cotton JA
    Elife; 2016 Mar; 5():. PubMed ID: 27003289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.